A groundbreaking, hour-long procedure using electrical currents to eliminate hard-to-reach prostate tumors is providing ...

Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...

The NHS, as well as experts in the field, have pointed out some red flags symptoms of prostate cancer that you should never ...

Learn how early detection of prostate cancer through screening and symptoms awareness leads to better outcomes.

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

Prostate cancer usually develops slowly, so there may be no signs of the health condition for many years, but once the tumour ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...

Prostate Cancer UK (PCUK) says one in eight men will get prostate cancer in their lifetime, and it’s the most common cancer – ...